Lonza buys InterHealth Nutraceuticals for up to €267m

©iStock

Related tags Nutrition Medicine Management Lonza

Swiss ingredients and pharma giant Lonza has agreed to pay up to $300 million (€267m) for Californian nutrient specialist InterHealth Nutraceuticals.

Lonza gains a suite of about 15 branded nutrients including its marquee collagen offering, UC-II.

“We are looking forward to welcoming the highly capable team to our Lonza family,” said Lonza CEO Richard Ridinger in a statement.

“They nicely complement our offerings and will be joining us in our quest to becoming the world’s leading and most-trusted supplier to the pharmaceutical, biotech and specialty ingredients markets. Lonza will be able to harness the proven management and branding capabilities and leverage them to a global level.”

The payment is split between an up-front payment and an earn-out payment.

Lonza said InterHealth – formerly owned by Kainos Capital - would continue to operate in the same premises with the same staff.

Otgher InterHealth offering include Meratrim for weight management; Relora for stress management; ChromeMate and Zychrome for blood sugar and insulin control and CardiaSlim for cholesterol management.